Abstract
Optical imaging is a rapidly developing field of research aimed at noninvasive monitoring of disease progression, evaluating the effects and pharmacokinetic of a drug, or identifying pathological biomarkers . To this end, it requires the development of targeting and highly specific contrast agents . In fluorescence imaging, an external light of appropriate wavelength is used to excite the fluorescent molecule, followed almost immediately by the release of longer wavelength, lower energy light for imaging. Fluorescence is increasingly used for imaging and has provided remarkable results. However this technique presents several limitations, especially due to tissue autofluorescence under external illumination and weak tissue penetration of low wavelength excitation light. To overcome these drawbacks, we have developed an innovative technique using persistent luminescence nanoparticles (PLNP) for optical imaging in small animal. Such nanoparticles can be excited before systemic injection, and their biodistribution monitored in real-time for dozen of minutes without the need for any external illumination source. This review article will focus on recent works undertaken in our laboratory on the synthesis of PLNP, their surface modifications and applications for bioimaging.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brannon-Peppas, L., Blanchette, J.O.: Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56, 1649–1659 (2004)
Brinker, C.J., Scherer, G.W.: Sol-Gel Science: The physics and the chemistry of sol-gel processing (1990) (academic London)
Byrne, J.D., Betancourt, T., Brannon-Peppas, L.: Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60, 1615–1626 (2008)
Chen, W., Mahmood, U., Weissleder, R., Tung, C.: Arthritis Imaging Using a Near-Infrared Fluorescence Folate-Targeted Probe. Arthritis Res.Ther. 7, R310–R317 (2005)
Choi, H.S.: Renal Clearance of Quantum Dots. Nat. Biotechnol. 25, 1165–1170 (2007)
Choy, E.H., Panayi, G.S.: Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907–916 (2001)
Courties, G., Presumey, J., Duroux-Richard, I., Jorgensen, C., Apparailly, F.: RNA interference-based gene therapy for successful treatment of rheumatoid arthritis. Expert Opin. Biol. Ther. 9, 535–538 (2009)
Greenwald, R.B.: PEG drug: an overview. J. Controlled Release 74, 159–171 (2001)
Jiang, L., Chang, C., Mao, D.: Luminescent properties of CaMgSi2O6 and Ca2MgSi2O7 phosphors activated by Eu2 + , Dy3 + and Nd3 + . J. Alloys Comp. 360, 193–197 (2003)
Kamps, J.A., Morselt, H.W.M., Swart, P.J., Meijer, D.K.F., Scherphof, G.L.: Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc. Natl. Acad. Sci. USA 94, 11681–11685 (1997)
Krieger, M., Herz, J.: Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein. Annu. Rev. Biochem. 63, 601–637 (1994)
Le Masne de Chermont, Q., Chanac, C., Seguin, J., Pelle, F., Matrejean, S., Jolivet, J.P., Gourier, D., Bessodes, M., Scherman, D.: Nanoprobes with Near-Infrared Persistent Luminescence for In Vivo Imaging. Proc. Natl. Acad. Sci. USA 104, 9266–9271 (2007)
Le Masne de Chermont, Q., Richard, C., Seguin, J., Chanac, C., Bessodes, M., Scherman, D.: Silicates doped with luminescent ions: useful tools for optical imaging applications. In: Proc. of SPIE, vol. 7189, 71890B/1–71890B/9 (2009)
Li, Z.F., Ruckenstein, E.: Water-soluble poly(acrylic acid) grafted luminescent silicon nanoparticles and their use as fluorescent biological staining labels. Nano. Lett. 4, 1463–1467 (2004)
Longmire, M., Choyke, P.L., Kobayashi, H.: Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3, 703–717 (2008)
Loomis, K., McNeeley, K., Bellamkonda, R.V.: Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications. Soft Matter 7, 839–856 (2011)
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K.: Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 65, 271–284 (2000)
Maldiney, T., Richard, C., Seguin, J., Wattier, N., Bessodes, M., Scherman, D.: Effect of core diameter, surface coating and PEG chain length on the biodistribution of persistent luminescent nanoparticles in mice. ACS Nano 5, 854–862 (2011)
Medintz, I.L., Uyeda, H.T., Goldman, E.R., Mattoussi, H.: Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mate. 4, 435–446 (2005)
Minchin, R.F., Martin, D.J.: Nanoparticles for molecular imaging - an overview. Endocrinology 151, 474–481 (2010)
Moghimi, S.M., Hunter, C., Murray, J.C.: Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53, 283–318 (2001)
Park, J.H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S.N., Sailor, M.J.: Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 8, 331–336 (2009)
Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R., Nann, T.: Quantum dots versus organic dyes as fluorescent labels. Nat. Methods 5, 763–775 (2008)
Richard, C., Le Masne de Chermont, Q., Scherman, D.: Nanoparticles for imaging and tumor gene delivery. Tumori 94, 264–270 (2008)
Salonen, J., Kaukonen, A.M., Hirvonen, J., Lehto, V.P.: Mesoporous silicon in drug delivery applications. J. Pharm. Sci. 97, 632–653 (2007)
Smith, A.M., Duan, H., Mohs, A.M., Nie, S.: Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug. Deliver Rev. 60, 1226–1240 (2008)
Song, Y.K., Liu, F.: Liu Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. Gene. Ther. 5, 1531–1537 (1998)
Tak, P.P., Taylor, P.C., Breedveld, F.C., Smeets, T.J.M., Daha, M.R., Kluin, P.M., Meinders, A.E., Maini, R.N.: Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum. 39, 1077–1081 (1996)
Wang, X.J., Jia, D., Yen, W.M.: Mn2 + activated green, yellow, and red long persistent phosphors. J. Lumin. 103, 34–37 (2003)
Weissleder, R., Pittet, M.J.: Imaging in the era of molecular oncology. Nature 452, 580–589 (2008)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Berlin Heidelberg
About this paper
Cite this paper
Richard, C. et al. (2012). Persistent Luminescence Nanoparticles for Bioimaging. In: Loménie, N., Racoceanu, D., Gouaillard, A. (eds) Advances in Bio-Imaging: From Physics to Signal Understanding Issues. Advances in Intelligent and Soft Computing, vol 120. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25547-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-25547-2_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25546-5
Online ISBN: 978-3-642-25547-2
eBook Packages: EngineeringEngineering (R0)